On April 17, 2024, Exact Sciences Corporation closed the transaction. The company issued 1.75% Senior Unsecured Convertible Notes due April 15, 2031 for a principal amount of $266,750,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.37 USD | -1.38% | -1.31% | -44.08% |
11/06 | Exact Sciences Seeks Acquisitions | CI |
11/06 | Transcript : Exact Sciences Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 03:20 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.08% | 7.74B | |
+8.98% | 3.56B | |
+3.94% | 2.28B | |
-24.94% | 1.89B | |
-17.38% | 1.75B | |
+4.89% | 939M | |
+21.75% | 751M | |
-11.57% | 674M | |
-30.82% | 485M | |
+4.37% | 304M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Exact Sciences Corporation announced that it has received $266.75 million in funding